Plasma resistin levels and risk of myocardial infarction and ischemic stroke

Cornelia Weikert1, Sabine Westphal, Klaus Berger

  • 1Department of Epidemiology, German Institute of Human Nutrition, Arthur-Scheunert-Allee 114-116, Nuthetal, Germany. weikert@dife.de

Insights

High plasma resistin levels predict increased risk of myocardial infarction (MI), but not ischemic stroke (IS). This study highlights resistin

Area of Science:

  • Endocrinology
  • Cardiovascular Disease Research
  • Biomarker Discovery

Background:

  • Resistin, a hormone, is implicated in insulin resistance and cardiovascular disease.
  • Previous studies suggest links between resistin and coronary heart disease.
  • Prospective data on resistin and future cardiovascular disease risk are limited.

Purpose of the Study:

  • To examine the association between plasma resistin levels and the risk of myocardial infarction (MI).
  • To investigate the association between plasma resistin levels and the risk of ischemic stroke (IS).
  • To provide prospective data on resistin's role in cardiovascular disease development.

Main Methods:

  • A case-cohort study design was employed within the European Investigation into Cancer and Nutrition-Potsdam Study.
  • Baseline plasma resistin levels were measured in 26,490 middle-aged participants.
  • Follow-up averaged 6 years, identifying incident MI, IS, or cardiovascular event-free individuals.

Main Results:

  • Individuals in the highest quartile of plasma resistin showed a significantly increased risk of MI (RR 2.09).
  • This association remained significant after adjusting for cardiovascular risk factors, including C-reactive protein.
  • No significant association was found between plasma resistin levels and the risk of IS (RR 0.94).

Conclusions:

  • Elevated plasma resistin levels are associated with a higher risk of myocardial infarction.
  • Plasma resistin levels do not appear to be significantly associated with the risk of ischemic stroke.
  • Further research is warranted to confirm the predictive value of resistin for cardiovascular events.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...